Skip to content
Screener

Bio-Rad Laboratories BIO Operating Lease Liability Payments Due

Operating Lease Liability Payments Due at other companies

Abbott logo
AbbottABT
$1.39B+5.5%
BioLife Solutions logo
BioLife SolutionsBLFS
$19.26M+17.6%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.48B+32.6%
Enterprise value$9.96B+21.5%
P/E56.2×+33.8×
P/S3.7×+0.9×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Year Ending December 31,Operating LeasesFinance Leases
202736.21.1
202828.41.1
202922.71.1
203017.41.1
Thereafter71.18.6
Total lease payments208.013.8
Less imputed interest(33.2)(4.7)
Total$174.8$9.1

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's operating lease liability payments due?
Bio-Rad Laboratories (BIO) reported operating lease liability payments due of $208M in Q1 2026.
How has Bio-Rad Laboratories's operating lease liability payments due changed year-over-year?
Bio-Rad Laboratories's operating lease liability payments due increased by 10.2% year-over-year, from $188.8M to $208M.
What does operating lease liability payments due mean?
This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.

Ask your AI about Bio-Rad Laboratories's operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude